missing translation for 'onlineSavingsMsg'
Learn More

Promega ApoLive-Glo™ Multiplex Assay DFS Item

The ApoLive-Glo™ Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death.

Supplier:  Promega G6410

 View more versions of this product

Catalog No. PRG6410


Only null left
Explore available promotions

Includes: GF-AFC Substrate, Assay Buffer, Caspase-Glo 3/7 Buffer, Caspase-Glo 3/7 Substrate

Description

Description

  • Measure Viability and Apoptosis in the Same Sample Well
  • Accurately determine mechanism of cell death in less time, with less sample
  • Easy to implement using a simple sequential 'add-mix-measure' protocol
  • Adaptable to meet various throughput needs
Specifications

Specifications

Fluorescence, Luminescence
10 mL
Bottle
Profile Compounds for Cytotoxic Risk
1 x 10 μL GF-AFC substrate, 1 x 10 mL Assay Buffer, 1 x 10 mL Caspase-Glo 3/7 Buffer, 1 x 1 bottle Caspase-Glo 3/7 substrate
-30°C to -10°C
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Promotions

Promotions

  • U.S. Patents 7,416,854; 7,553,632 and other patents pending.
  • U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
  • U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
  • The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.